Clinical Trial Update: A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [Phase 1, Phase 2]

View source ↗

Summary

An early-phase study to evaluate the safety and tolerability of ALN-PNP in healthy adults and adults with MASLD, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• ALN-PNP (ALN-PNP)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Healthy Volunteers, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Phase 1, Phase 2 | Status: RECRUITING